Is a nitroglycerin patch effective for treating epicondylitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Nitroglycerin Patch for Epicondylitis

Nitroglycerin patches can be considered as an adjunct treatment for chronic lateral epicondylitis that has not responded to first-line conservative therapies, though the evidence shows only short-to-mid-term benefits with no clear long-term advantage. 1, 2

First-Line Treatment Approach

The standard initial management of epicondylitis should include: 3

  • Relative rest from aggravating activities 3
  • Eccentric strengthening exercises as the cornerstone of rehabilitation 3
  • NSAIDs for acute pain management 3
  • Corticosteroid injections which demonstrate superior short-term efficacy (92% improvement at 4 weeks versus 50% with placebo) 4

Nitroglycerin is not recommended as first-line monotherapy but rather as an adjunct to eccentric strengthening programs when initial conservative measures have failed. 1

Evidence for Nitroglycerin in Epicondylitis

Short-to-Mid-Term Benefits

The research demonstrates modest effectiveness in specific timeframes:

  • At 3 weeks: Significant pain reduction with mean VAS scores of 3.15 in the GTN group versus 6.45 in controls (p=0.001), with 90% of patients reporting successful treatment 5
  • At 6 months: Continued benefit with mean VAS scores of 0.70 versus 4.85 in controls (p=0.001) 5
  • Up to 6 months: Systematic review evidence supports improvement in elbow pain and function 2

Long-Term Limitations

At 5 years post-treatment, nitroglycerin showed no sustained benefit, indicating that any positive effects are temporary. 2

A comprehensive meta-analysis found no evidence that NTG is more effective than placebo when examining all available data across tendinopathies, with effects being "insignificant or borderline significant" for lateral epicondylitis specifically. 6

Practical Application Guidelines

Dosing Protocol

When nitroglycerin is used, the evidence supports: 2

  • 1.25 mg/24 hours (most commonly studied dose) 2
  • Alternative dosing of 1.44 mg/24 hours has also been evaluated 2
  • Applied once daily to the area of maximal tenderness 5

Essential Combination Therapy

Topical NTG is more effective when combined with a tendon rehabilitation program rather than used as monotherapy. 2 This means continuing eccentric strengthening exercises while using the patch.

Common Side Effects to Counsel Patients About

  • Headaches (most common) 2
  • Contact dermatitis at application site 2

Critical Contraindications

Before prescribing nitroglycerin patches, screen for: 1

  • Hypotension (systolic BP <90 mmHg) 1
  • Severe bradycardia (<50 bpm) 1
  • Concurrent phosphodiesterase inhibitor use (sildenafil, tadalafil, vardenafil) 1

Clinical Decision Algorithm

  1. Initial presentation: Start with eccentric strengthening, NSAIDs, and activity modification 3

  2. Persistent symptoms at 2-4 weeks: Consider corticosteroid injection, which has the strongest evidence for short-term relief (92% improvement rate) 4

  3. Chronic symptoms (>6-12 weeks) unresponsive to above: Consider adding nitroglycerin patch as adjunct to ongoing eccentric exercises 1, 2

  4. Failure after 3-6 months of comprehensive conservative therapy: Surgical consultation becomes the definitive option 1

Important Caveats

The mechanism of benefit remains unclear, though theories include improved collagen synthesis and increased blood flow to hypovascular tendon regions. 1 This theoretical basis is not well-established.

Alternative modalities with moderate evidence include ultrasound therapy and laser therapy, which may be considered alongside or instead of nitroglycerin. 7

The evidence quality for nitroglycerin is mixed, with individual studies showing benefit but meta-analyses failing to demonstrate clinically significant superiority over placebo. 6 This suggests that any benefit may be modest and patient-specific, making it reasonable to trial but not expect universal success.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.